Connection

Fang Zheng to Treatment Outcome

This is a "connection" page, showing publications Fang Zheng has written about Treatment Outcome.
Connection Strength

0.097
  1. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. J Integr Med. 2020 09; 18(5):395-400.
    View in: PubMed
    Score: 0.032
  2. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis. Pathol Res Pract. 2019 Jan; 215(1):5-11.
    View in: PubMed
    Score: 0.028
  3. Epidemiology and clinical course of COVID-19 in Shanghai, China. Emerg Microbes Infect. 2020 Dec; 9(1):1537-1545.
    View in: PubMed
    Score: 0.008
  4. First patient management of COVID-19 in Changsha, China: a case report. BMC Infect Dis. 2020 Nov 11; 20(1):824.
    View in: PubMed
    Score: 0.008
  5. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex. J Med Virol. 2020 10; 92(10):2050-2054.
    View in: PubMed
    Score: 0.008
  6. KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China. Virol Sin. 2018 08; 33(4):369-372.
    View in: PubMed
    Score: 0.007
  7. Percutaneous Intraluminal Radiofrequency Ablation for Malignant Extrahepatic Biliary Obstruction: A Safe and Feasible Method. Dig Dis Sci. 2015 Jul; 60(7):2158-63.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.